medigraphic.com

2020, Number 1

Next >>

Rev Hematol Mex 2020; 21 (1)

Immediate adverse effects of transfusion in children

Bravo-Lindoro AG

Language: Spanish
References: 18
Page: 1-7
PDF size: 284.49 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Oakley F, Woods M, Arnold S, Young P. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products. Transfusion 2015; 55:563-70. doi: 10.1111/trf.12827

  2. Delaney M, Wendel S, et al. Transfusion reactions, prevention, diagnostic and treatment. Lancet 2016;388(10061):2825-2836. doi: 10.1016/S0140- 6736(15)01313-6.

  3. Whitaker BI, Rajbhandary S, Harris A. The 2013 AABB blood collection, utilization, and patient blood management survey report (Internet) Bethesda: AABB;2015[cited 2019 Sep 9]. Available from: https://www.aabb.org/research/ hemovigilance/bloodsurvey/Documents/2013-AABBBlood- Survey-Report.pdf

  4. Vassoughi S, Perez G, Whitaker B, Fung M, Stotler B. Analysis of pediatric adverse reactions to transfusions. Transfusion 2017;00:1-9. doi: 10.1111/trf.14359.

  5. Yanagisawa R, Shimodaira S, et al. Factors related to allergic transfusion reactions and febrile non-hemolytic transfusion reactions in children. Vox Sang 2016;110:376-384. doi: 10.1111/vox.12373.

  6. Bravo A, Aguilar D, Bejar Y. Efectos adversos no infecciosos de la transfusión sanguínea. En: Terapia Transfusional en Pediatría. Prado, 2009;481-511.

  7. Tinegate H, Birchall J, Gray A, et al, and the BCSH Blood Transfusion Task Force. Guideline of the investigation and management of acute transfusion reactions. Prepared by de BCSH Blood Transfusion Task Force. Br J Haematol 2012;159:143-53. doi: 10.1111/bjh.12017.

  8. Kopko P, Golsfinger D. Modern approaches to the diagnosis and management of red cell transfusion reaction. Red Cell Transfusion. Reid M, Nance S, editors. Humana Press 1998:189-204.

  9. Bravo A. Reacción hemolítica aguda. Rev Mex Med Tran 2010;1:18-21.

  10. Norma Oficial Mexicana NOM-253-SSA1-2012 “Para el uso de sangre y sus componentes con fines terapéuticos”.

  11. Savage W. The unique challenges of hemovigilance for pediatric patients. Transfusion 2015;55:466-7. doi: 10.1111/ trf.12955.

  12. Bolton-Maggs. Transfusion and hemovigilance in pediatrics. Pediatr Clin North Am 2013;60:1527-1540. doi: 10.1016/j.pcl.2013.08.010.

  13. Muñiz E, León G, Torres O. Manual Iberoamericano de Medicina Transfusional. 2015

  14. Carson J, Triulzi D, Ness P. Indications for and adverse effects of red-cell transfusion. N Engl J Med 2017;377:1261-1272. DOI: 10.1056/NEJMra1612789.

  15. Radillo A. Reacciones adversas a de la transfusión y su manejo. En: Medicina Transfusional. 3ª ed. Prado, 2017. 607-303.

  16. Cohn CS, Stubbs JS, Schwarch J, et al. A comparison of adverse reactions rates for PAS C versus plasma platelet units. Transfusion 2014;54:1927-34. doi: 10.1111/trf.12597.

  17. Serious Hazards of Transfusion (SHOT-Report-2018). (Internet) Consultado 8 de septiembre 2019 Available from: https://www.shotuk.org/wp-content/uploads/myimages/ SHOT-Report-2018.Web_Version.pdf -Report.pdf

  18. Wiersum-Osselton J, Whitaker BL, Grey S, et al. Revised international surveillance case definition of transfusion associated circulatory overload: a classification agreement validation study. Lancet Haematol 2019;6:e350-58. doi: 10.1016/S2352-3026(19)30080-8.




2020     |     www.medigraphic.com